T 0215/01 (Method of inhibiting HIV replication: OKLAHOMA MEDICAL RESEARCH FOUNDATION, et al) of 07.04.2005
- European Case Law Identifier
- ECLI:EP:BA:2005:T021501.20050407
- Date of decision
- 7 April 2005
- Case number
- T 0215/01
- Online on
- 7 April 2005
- Petition for review of
- -
- Application number
- 90909103.5
- IPC class
- A61K 31/35
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Antiviral therapy using thiazine and xanthene dyes
- Applicant name
- Oklahoma Medical Research Foundation, et al
- Opponent name
- Blutspendedienst der Landesverbände des DRK Niedersachsen,
Sachsen-Anhalt, Thüringen, Oldenburg und Bremen gGmbH
Baxter International Inc. - Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 111(1) 1973European Patent Convention Art 123(2) 1973European Patent Convention Art 56 1973
- Keywords
- Main request and auxiliary request 1 - inventive step - (no): use of methylene blue obvious
Auxiliary requests 2 and 3 - added matter - (yes): methods carried out independently "in vitro" and "in vivo"
provide no support for a method carried out"ex vivo"
Remittal (no) - Catchword
- -
- Cited cases
- -
- Citing cases
- T 1614/06
ORDER
For these reasons it is decided that:
The appeal is dismissed.